Azithromycin Pill
Phase 3Small molecule
Azithromycin Pill is one of 17 small molecule programs targeting Antibiotics. It is currently in Phase 3.
3
Indications
6
Total Trials
4
Active Trials
16
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
17 competitors in Antibiotics
#DrugCompanyPhaseTrials
1Vancocin
HHikma Pharmaceuticals LLC
Approved
Amoxil
GGlobal Antibiotics Research and Development Partnership
Approved
Ancef
BBaxter Healthcare Corporation
Approved
Levaquin
WWim Janssens
Approved
Flagyl
DDePuy Orthopaedics
Phase 3
Cipro
BayerPhase 2
Xtandi
AstellasPhase 2
Sulfamethoxazole-Trimethoprim
NNational Institute of Allergy and Infectious Diseases (NIAID)
Phase 3
Azithromycin Pill
RRambam Health Care Campus
Phase 3
Floxin
WWim Janssens
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Azithromycin2 trials
Azithromycin Before Induction
Recruiting·—·Phase 1·NCT06543290·400 enrolled
Antibiotics1 trial
Crohn's Disease Relapse1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Azithromycin Pill. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- RRambam Health Care Campus